what are some side effects of semaglutide Comparative safety and and tirzepatide: Implications for clinical decision-making in obesity management What to Expect After First

Image from Coleski et al

An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP

The guide on retatrutide dosing decisions helps evaluate this trade-off

Weight loss which exceeds what is expected in an older adult treated with GLP-1 receptor agonist should be investigated to exclude malignancy

De La Cruz frequently treats patients requiring revision liposuction or correction of contour irregularities from prior procedures

Dimitris Papamargaritis has acted as a speaker for Novo Nordisk, Eli Lilly and Boehringer Ingelheim and Johnson and Johnson and has received grants from Novo Nordisk, Novo Nordisk UK Research Foundation, Academy of Medical Sciences/Diabetes UK, Health Education East Midlands and the NIHR